Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Boston Scientific (BSX) Any Comments??? -- Ignore unavailable to you. Want to Upgrade?

To: Lighthouse who wrote (729)	3/20/2000 10:38:00 AM
From: Mike	Respond to of 798

Disclaimer- I am not long or short this stock. I would love to buy in at the appropriate time. Trying to find when that is. Thanks for the followup. I think at some point BSX will be a great buy either for new shareholders or an acquirer. It is my opinion that the new stents coming out (Nir Royal and Sox) will at best stabalize market share. This is a sorry thing to state but true. I have spoken with many people in the field that share this view. The Medinol issue leads to the worst margins in the industry. I also have heard that pricing is starting to come down. Not dramatic but coming down none the less. This is putting pressure on the companies having trouble holding market share and industry leaders (GDT). The stock will be a great buy once the house is put in order. But many times to get a stock at the bottom you have to buy when everyone else is saying sell. Good luck, Mike